279 related articles for article (PubMed ID: 19147845)
1. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.
Calado RT; Regal JA; Hills M; Yewdell WT; Dalmazzo LF; Zago MA; Lansdorp PM; Hogge D; Chanock SJ; Estey EH; Falcão RP; Young NS
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1187-92. PubMed ID: 19147845
[TBL] [Abstract][Full Text] [Related]
2. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
3. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
5. The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
Both A; Krauter J; Damm F; Thol F; Göhring G; Heuser M; Ottmann O; Lübbert M; Wattad M; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Brugger W; Schlegelberger B; Heil G; Ganser A; Wagner K
Ann Hematol; 2017 Jun; 96(6):895-904. PubMed ID: 28331964
[TBL] [Abstract][Full Text] [Related]
6. Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).
Aref S; El-Ghonemy MS; Abouzeid TE; El-Sabbagh AM; El-Baiomy MA
Med Oncol; 2014 Sep; 31(9):158. PubMed ID: 25108601
[TBL] [Abstract][Full Text] [Related]
7. Telomerase gene mutation screening and telomere overhang detection in Chinese patients with acute myeloid leukemia.
Yan S; Han B; Wu Y; Zhou D; Zhao Y
Leuk Lymphoma; 2013 Jul; 54(7):1437-41. PubMed ID: 23157242
[TBL] [Abstract][Full Text] [Related]
8. A spectrum of severe familial liver disorders associate with telomerase mutations.
Calado RT; Regal JA; Kleiner DE; Schrump DS; Peterson NR; Pons V; Chanock SJ; Lansdorp PM; Young NS
PLoS One; 2009 Nov; 4(11):e7926. PubMed ID: 19936245
[TBL] [Abstract][Full Text] [Related]
9. Constitutional telomerase mutations are genetic risk factors for cirrhosis.
Calado RT; Brudno J; Mehta P; Kovacs JJ; Wu C; Zago MA; Chanock SJ; Boyer TD; Young NS
Hepatology; 2011 May; 53(5):1600-7. PubMed ID: 21520173
[TBL] [Abstract][Full Text] [Related]
10. Telomere maintenance and human bone marrow failure.
Calado RT; Young NS
Blood; 2008 May; 111(9):4446-55. PubMed ID: 18239083
[TBL] [Abstract][Full Text] [Related]
11. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
[TBL] [Abstract][Full Text] [Related]
12. Telomeres and marrow failure.
Calado RT
Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
[TBL] [Abstract][Full Text] [Related]
13. TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity.
Terada K; Miyake K; Yamaguchi H; Miyake N; Yamanaka K; Kojima S; Ito E; Inokuchi K; Okada T
Int J Lab Hematol; 2020 Jun; 42(3):316-321. PubMed ID: 32150348
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
[TBL] [Abstract][Full Text] [Related]
15. Clinical mutations in the TERT and TERC genes coding for telomerase components induced oxidative stress, DNA damage at telomeres and cell apoptosis besides decreased telomerase activity.
Fernández-Varas B; Manguan-García C; Rodriguez-Centeno J; Mendoza-Lupiáñez L; Calatayud J; Perona R; Martín-Martínez M; Gutierrez-Rodriguez M; Benítez-Buelga C; Sastre L
Hum Mol Genet; 2024 Apr; 33(9):818-834. PubMed ID: 38641551
[TBL] [Abstract][Full Text] [Related]
16. The effect of TERC haploinsufficiency on the inheritance of telomere length.
Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
[TBL] [Abstract][Full Text] [Related]
17. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
[TBL] [Abstract][Full Text] [Related]
18. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Hills M; Lansdorp PM
Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
[TBL] [Abstract][Full Text] [Related]
20. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Katzenstein AL; Godwin JD; Raghu G; Glazer CS; Rosenblatt RL; Girod CE; Garrity ER; Xing C; Garcia CK
PLoS One; 2010 May; 5(5):e10680. PubMed ID: 20502709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
